Pulmonology Congress 2026 | Advanced Pulmonology 2026 | Lung Health Conference 2026

The International Conference on Advanced Pulmonology & Lung Health 2026 is a premier global platform dedicated to exploring innovations, clinical practices, and research breakthroughs in respiratory medicine. The conference aims to bring together pulmonologists, thoracic surgeons, researchers, healthcare professionals, and industry experts from across the world to discuss current challenges and future directions in lung health.

This event focuses on a broad spectrum of topics such as asthma, COPD, lung cancer, tuberculosis, pulmonary fibrosis, respiratory infections, sleep apnea, and critical care medicine. It provides a dynamic forum to exchange scientific knowledge, clinical experiences, and emerging technologies shaping respiratory care and disease prevention.

With keynote lectures from leading specialists, panel discussions on clinical advancements, and research sessions on translational science, the conference aims to bridge the gap between innovation and patient-centered treatment.

Join us to experience two days of powerful learning, networking, and collaboration that will shape the future of global lung health.

Market Analysis The global pulmonology and respiratory care market is undergoing a transformative phase driven by increasing cases of chronic respiratory diseases and rapid advancements in diagnostic and therapeutic technologies. The global respiratory care market was valued at USD 26 billion in 2024 and is projected to reach USD 45 billion by 2032, growing at a CAGR of 6.5%. Chronic respiratory conditions such as COPD, asthma, and lung cancer are among the top causes of death globally, contributing to more than 4 million deaths annually. The demand for ventilation devices, inhalation therapies, and pulmonary diagnostics has surged following the COVID-19 pandemic, highlighting the need for resilient lung health systems. Increasing investments in AI-based respiratory diagnostics, telepulmonology, and personalized treatments are fueling growth in both developed and emerging markets. Major industry players like Philips Healthcare, ResMed, Fisher & Paykel Healthcare, Medtronic, and AstraZeneca are driving innovation through research collaborations and technological integration. The conference serves as a global knowledge exchange platform to discuss clinical progress, policy frameworks, and market opportunities shaping the future of pulmonology and respiratory care.